Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Coexistence of triple-seronegative myasthenia gravis and pathology-proven cryptogenic organizing pneumonia. | Front Neurol | 2023 | 38046596 | PubTator, text mining | PubMed |
| The Role of Thymoma and Thymic Hyperplasia as Prognostic Risk Factors for Secondary Generalisation in Adults with Ocular Myasthenia Gravis: A Systematic Narrative Review. | Br Ir Orthopt J | 2023 | 38046270 | PubTator, text mining | PubMed |
| Pembrolizumab-induced Myopathy with Anti-striated Muscle Antibodies Successfully Treated by Plasma Exchange. | Intern Med | 2023 | 38044116 | PubTator, text mining | PubMed |
| Residual serum fibrinogen as a universal biomarker for all serotypes of Myasthenia gravis. | Sci Rep | 2023 | 38040826 | PubTator, text mining | PubMed |
| Hip Fracture in a Patient with Overlap Syndrome - Conundrums Involved in the Management - A Case Report. | J Orthop Case Rep | 2023 | 38025370 | PubTator, text mining | PubMed |
| Problems with studying directional natural selection in humans. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 38023807 | PubTator, text mining | PubMed |
| Diagnostic dilemmas and challenges in the management of myasthenia in infants and toddlers: A case report. | SAGE Open Med Case Rep | 2023 | 38022851 | PubTator, text mining | PubMed |
| Efficacy and safety of the innovative monoclonal antibodies in adults with generalized myasthenia gravis: a Bayesian network analysis. | Front Immunol | 2023 | 38022544 | PubTator, text mining | PubMed |
| Psychogenic Dysphagia in an Elderly: A Case of Eating Disorder Due to Trauma and Grief. | Cureus | 2023 | 38021874 | PubTator, text mining | PubMed |
| Molecular Analysis of a Congenital Myasthenic Syndrome Due to a Pathogenic Variant Affecting the C-Terminus of ColQ. | Int J Mol Sci | 2023 | 38003406 | PubTator, text mining | PubMed |
| Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics. | Biomolecules | 2023 | 38002264 | PubTator, text mining | PubMed |
| Homozygous Duplication in the CHRNE in a Family with Congenital Myasthenic Syndrome 4C: 18-Year Follow Up. | Biomedicines | 2023 | 38001983 | PubTator, text mining | PubMed |
| Methionine Promotes Milk Protein Synthesis via the PI3K-mTOR Signaling Pathway in Human Mammary Epithelial Cells. | Metabolites | 2023 | 37999245 | PubTator, text mining | PubMed |
| Unsolved Issues in Thymic Epithelial Tumour Stage Classification: The Role of Tumour Dimension. | Diagnostics (Basel) | 2023 | 37998604 | PubTator, text mining | PubMed |
| CAR T cells for treating autoimmune diseases. | RMD Open | 2023 | 37996128 | PubTator, text mining | PubMed |
| Clinical Outcomes in AchR Antibody-Positive Myasthenia Gravis: Where Does Rituximab Stand in the Current Times? | Ann Indian Acad Neurol | 2023 | 37970317 | PubTator, text mining | PubMed |
| Clinical Profile and Quality of Life in Myasthenia Gravis Using MGQOL15 R(Hindi): An Indian Perspective. | Ann Indian Acad Neurol | 2023 | 37970285 | PubTator, text mining | PubMed |
| ACHR-Positive Generalized Myasthenia Gravis: The Old is Gold and the New Is for us to Explore. | Ann Indian Acad Neurol | 2023 | 37970281 | PubTator, text mining | PubMed |
| The Clinical Outcome in AChR-Positive Generalized Myasthenia Gravis: A Retrospective Observational Study. | Ann Indian Acad Neurol | 2023 | 37970279 | PubTator, text mining | PubMed |
| Progressive Bulbar Palsy with Facial Diplegia and Proximal Weakness Diagnosed as Juvenile-Onset Myasthenia Gravis. | Ann Indian Acad Neurol | 2023 | 37970251 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=18